Get the Stockscreener App
0.00
100.00%
-0.103
Applied Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.103
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$14.86M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
0.00
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.00 | 14.86M | 0 | -119.76M | -55.17M | -1.35 |
VRTX
Vertex Pharmaceuticals Inc
|
444.93 | 112.92B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
612.14 | 64.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
893.52 | 55.57B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.85 | 37.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.87 | 32.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-03-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - TMX Newsfile
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) - GuruFocus
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - TMX Newsfile
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian - PharmiWeb.com
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations - BioSpace
Here's why Applied Therapeutics (APLT) is a great 'buy the bottom' stock now - MSN
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
Applied Therapeutics, Inc. (APLT) - Minichart
Aug Swings: Should I set a stop loss on Applied Therapeutics Inc2026 Review & Safe Entry Momentum Tips - baoquankhu1.vn
Panic Selling: Is Applied Therapeutics Inc backed by strong institutional buyingQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn
New Highs: Can Applied Therapeutics Inc keep up with sector leaders2026 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Momentum Shift: What is Applied Therapeutics Incs valuation compared to sectorMarket Activity Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Aug Movers: Is Applied Therapeutics Inc stock good for income investors2026 Macro Impact & Weekly Return Optimization Alerts - baoquankhu1.vn
Aug Volume: Can Applied Therapeutics Inc continue delivering strong returns2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN
APLT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Earnings Report: Can Applied Therapeutics Inc continue delivering strong returns2026 Opening Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
Published on: 2026-03-31 11:48:00 - baoquankhu1.vn
Sentiment Recap: Can Applied Therapeutics Inc continue delivering strong returns2026 Market Mood & Smart Swing Trading Alerts - baoquankhu1.vn
Panic Selling: Can Applied Therapeutics Inc keep up with sector leaders2026 Technical Patterns & Verified Technical Trade Signals - baoquankhu1.vn
Published on: 2026-03-25 10:49:57 - baoquankhu1.vn
Applied Therapeutics shifts social media operations to Cycle Pharmaceuticals - Traders Union
If You Invested $1,000 in Applied Therapeutics (APLT) - Stock Titan
Sentiment Review: Is Applied Therapeutics Inc gaining market share2026 Update & Accurate Intraday Trade Tips - baoquankhu1.vn
Sectors Review: Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn
AI Stocks: Should I set a stop loss on Applied Therapeutics IncProduct Launch & Smart Allocation Stock Reports - baoquankhu1.vn
Aug Highlights: Is Applied Therapeutics Inc stock good for income investors2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
APLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Applied Therapeutics completes merger with Cycle Group Holdings, delists from Nasdaq - Investing.com Nigeria
Momentum Shift: How does Applied Therapeutics Inc score in quality rankings2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
Should you buy the dip on Applied Therapeutics Inc.Watch List & High Accuracy Buy Signal Tips - mfd.ru
IPO Launch: Can Applied Therapeutics Inc keep up with sector leadersDollar Strength & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Can Applied Therapeutics Inc. keep up with sector leadersMarket Sentiment Review & Smart Allocation Stock Reports - mfd.ru
[15-12G] Applied Therapeutics, Inc. SEC Filing - Stock Titan
Will Applied Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru
Highs Report: What are Applied Therapeutics Incs recent SEC filings showing2025 Price Action Summary & Technical Pattern Based Signals - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio By Investing.com - Investing.com Nigeria
Merger pays $0.088 + CVR for Applied Therapeutics (NASDAQ: APLT) - Stock Titan
Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc.. - marketscreener.com
Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma
Applied Therapeutics completes merger and Nasdaq delisting move - TipRanks
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio - Investing.com
Applied Therapeutics Announces Board and Management Changes Following Merger - TradingView
Applied Therapeutics, Inc. Announces Management Changes - marketscreener.com
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire
Applied Therapeutics (APLT) CCO exits stake after $0.088-per-share cash and CVR deal - Stock Titan
Sectors Review: Will Applied Therapeutics Inc benefit from seasonalityGap Up & Expert Curated Trade Ideas - baoquankhu1.vn
Earnings Recap: Can EFCPRA reach all time highs this yearRate Cut & Smart Swing Trading Techniques - baoquankhu1.vn
APLT Stock Chart | APPLIED THERAPEUTICS INC (NASDAQ:APLT) - ChartMill
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):